BRESCIA, Italy, Sept. 17, 2021 /PRNewswire/ — On Friday, August 27, 2021, the United States International Trade Commission instituted an unfair importation investigation, conducted pursuant to 19 U.S.C. § 1337, against several manufacturers and distributors of imported flocked swabs and products containing the flocked swabs. The investigation is entitled In the Matter of Certain Flocked Swabs, Products Containing Flocked Swabs, and Methods of Using Same, No. 337-TA-1279.
In the complaint, Copan Italia S.p.A. and its Puerto Rico based manufacturing subsidiary alleged that the accused devices and products infringe several of its U.S.-issued patents, and requested an exclusion order against the named respondents, as well as a general exclusion seeking an order directing U.S. Customs to stop the infringing imports from entering the United States. Copan’s founder, Daniele Triva, invented flocked swabs, and this critically important patented technology led to major advancements in the collection of biological specimens and automated laboratory systems. Copan has made a significant investment in the expansion of its U.S. facilities, and its domestic production capacity, and has created hundreds of jobs in the United States
With a reputation for innovation, COPAN is the leading manufacturer of collection and transport systems in the world. COPAN’s collaborative approach to pre-analytics has resulted in Flocked Swabs, ESwab™, UTM Universal Transport Medium®, and laboratory automation, WASP® and WASPLab®. COPAN carries a range of microbial sampling products, inoculation loops, and pipettes. For more information, visit www.copangroup.com
SOURCE COPAN Group
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.